US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cardiome Pharma

2.34

0.0000

Volume:- -

Turnover:- -

Market Cap:47.14M

PE:-2.82

High:2.34

Open:2.34

Low:2.34

Close:2.34

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Cardiome Pharma

Exchange:

NASDAQ

Establishment Date:

- -

Employees:

- -

Office Location:

- -

Website:

http://www.cardiome.com

Zip Code:

- -

Phone:

- -

Fax:

- -

Introduction:

Cardiome Pharma Corp., a specialty pharmaceutical company, engages in the development and commercialization of cardiovascular therapies that enhance the life and health of patients suffering from heart diseases. It offers BRINAVESS (vernakalant IV) for the conversion of recent onset atrial fibrillation to sinus rhythm in adults; and AGGRASTAT, a reversible GP IIb/IIIa inhibitor for use in acute coronary syndrome patients. The company also provides ESMOCARD and ESMOCARD LYO short-acting beta-blockers used to control rapid heart rate; and develops TREVYENT for use in treating pulmonary arterial hypertension. It has operations in Canada, the United States, Europe, and internationally. The company was formerly known as Nortran Pharmaceuticals Inc. and changed its name to Cardiome Pharma Corp. in June 2001. Cardiome Pharma Corp. was founded in 1986 and is based in Vancouver, Canada.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CRME/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CRME","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CRME\",,,,,undefined,":{"symbol":"CRME","market":"US","secType":"STK","nameCN":"Cardiome Pharma","latestPrice":2.34,"timestamp":1526500800000,"preClose":2.34,"halted":4,"volume":0,"delay":0,"floatShares":15720000,"shares":20147000,"eps":-0.83,"marketStatus":"Delisted","change":0,"latestTime":"05-16 16:00:00 EDT","open":2.34,"high":2.34,"low":2.34,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.83,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1748505600000},"marketStatusCode":0,"symbolChange":{"newSymbol":"CORV","executeDate":"2018-05-17"},"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":2.34,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CRME\",,,,,undefined,":{"symbol":"CRME","floatShares":15720000,"roa":"--","roe":"--","lyrEps":0,"shares":20147000,"dividePrice":0,"high":2.34,"amplitude":0,"preClose":2.34,"low":2.34,"week52Low":1.29,"pbRate":"2.02","week52High":4.84,"institutionHeld":0.0951,"latestPrice":2.34,"eps":-0.83,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.83,"open":2.34},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.cardiome.com","stockEarnings":[{"period":"1week","weight":0.0043},{"period":"1month","weight":0.0043},{"period":"3month","weight":0.0043},{"period":"6month","weight":0.0043},{"period":"1year","weight":0.0043},{"period":"ytd","weight":0.0043}],"compareEarnings":[{"period":"1week","weight":0.0084},{"period":"1month","weight":0.067},{"period":"3month","weight":0.0046},{"period":"6month","weight":-0.0246},{"period":"1year","weight":0.1093},{"period":"ytd","weight":0.0028}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Cardiome Pharma Corp., a specialty pharmaceutical company, engages in the development and commercialization of cardiovascular therapies that enhance the life and health of patients suffering from heart diseases. It offers BRINAVESS (vernakalant IV) for the conversion of recent onset atrial fibrillation to sinus rhythm in adults; and AGGRASTAT, a reversible GP IIb/IIIa inhibitor for use in acute coronary syndrome patients. The company also provides ESMOCARD and ESMOCARD LYO short-acting beta-blockers used to control rapid heart rate; and develops TREVYENT for use in treating pulmonary arterial hypertension. It has operations in Canada, the United States, Europe, and internationally. The company was formerly known as Nortran Pharmaceuticals Inc. and changed its name to Cardiome Pharma Corp. in June 2001. Cardiome Pharma Corp. was founded in 1986 and is based in Vancouver, Canada.","exchange":"NASDAQ","name":"Cardiome Pharma","nameEN":"Cardiome Pharma"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"CRME\",market:\"US\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CRME\",params:#limit:5,,,undefined,":[{"date":"2018-05-17","symbol":"CRME","newSymbol":"CORV","type":"symbolChange","dateTimestamp":1526529600000},{"market":"US","date":"2018-05-15","symbol":"CRME","fiscalQuarterEnding":"2018/03","expectedEps":-0.22,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1526356800000,"reportTimeType":"post","actualEps":-0.24},{"market":"US","date":"2018-03-13","symbol":"CRME","fiscalQuarterEnding":"2017/12","expectedEps":-0.19,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1520913600000,"reportTimeType":"post","actualEps":-0.24},{"market":"US","date":"2017-11-14","symbol":"CRME","fiscalQuarterEnding":"2017/09","expectedEps":-0.16,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1510635600000,"reportTimeType":"post","actualEps":-0.2},{"market":"US","date":"2017-08-08","symbol":"CRME","fiscalQuarterEnding":"2017/06","expectedEps":-0.18,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1502164800000,"reportTimeType":"post","actualEps":-0.26}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CRME\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CRME\",market:\"US\",delay:false,,,undefined,":{}}}